Technician Advanced Training Microcredentials | Point-of-Care Testing /Test & Treat Written 4 credit hours PTCB Approved

Save money on your Point of Care Testing for Pharmacy Technicians journey by bundling our training program and PTCB’s Point of Care Testing Assessment-based Certificate Program.

Now more than ever, pharmacies are considered a place for front-line delivery of healthcare. This 4-hour training will equip you with the necessary skills to administer point-of-care tests in the pharmacy. Don’t miss the opportunity to assist pharmacists with testing services for your pharmacy’s patients.

This package includes:

  • CEimpact’s Point of Care Testing for Pharmacy Technicians Advanced Training Course
  • PTCB’s Point-of-Care Testing Certificate for Pharmacy Technicians (Regularly $89)

Here’s how it works:

  1. Purchase this bundle
  2. Complete the CEimpact Point of Care Testing for Pharmacy Technicians Advanced Training Course
  3. Receive an access code to take PTCB’s Point-of-Care Testing Assessment-based Certificate Program Exam at no additional cost!

This 4-hour training prepares pharmacy technicians to support point-of-care testing services in the pharmacy setting, in alignment with current clinical practices and regulatory requirements.

Designed as a microcredential program, this course provides focused, practical training and awards a digital badge upon successful completion.

Course content includes:

  • Compliance requirements, including how to obtain a CLIA waiver
  • Procedures for PPE, specimen collection, and device selection
  • Testing procedures for diabetes and hyperlipidemia
  • Administration of tests for COVID-19, Influenza, HIV, Hepatitis C, and Group A Strep
  • Documentation of hands-on specimen collection techniques tailored to pharmacy workflow

Technicians also explore current trends in pharmacy practice, the evolving role of technicians in testing services, and appropriate follow-up actions after testing to support patient care.

This training emphasizes practical application, including selecting appropriate testing methods, collecting specimens, and supporting workflow integration within the pharmacy.

The program is designed to help pharmacy technicians build specialized skills, contribute more directly to patient care services, and prepare for expanded responsibilities within an evolving pharmacy practice environment.

Earn your microcredential and build practical testing skills – enroll today.

Point-of-Care Testing - Technician

Claim Your Badge

You will receive an email from Credly (our credential partner), after you complete the course, inviting you to claim your digital badge for Point-of-Care Testing - Technician. This will allow you to easily share your achievement with colleagues, managers, and your professional network on LinkedIn and other platforms. When you receive the email, please click the button and create an account on Credly.com so that you can “accept” the badge.

Need help? Find a step-by-step tutorial video at this link.

Learning Objectives

Upon completion of the full course, pharmacy technicians should be able to:
1. Describe current trends in pharmacy practice and point of care testing (POCT)
2. List the pros/cons of implementing point of care testing
3. Identify the role pharmacists and pharmacy technicians can play in providing point of care testing services
4. Describe the process to obtain a clinical laboratory improvement amendment (CLIA) waiver license
5. List appropriate follow-up actions needed after conducting point of care testing (both internal and external)
6. Review the Centers for Disease Control and Prevention Self-Assessment Checklist for Good Testing Practice
7. Find CLIA resources and locate forms to assist in standardizing the point of care testing process
8. Review personal protective equipment (PPE) requirements for various POCTs
9. Compare and contrast the devices needed to administer an appropriate POCT
10. Collect specimen for diagnostic testing through nasal, throat, or blood routes
11. Describe patient characteristics for an individual at risk for diabetes and/or hyperlipidemia or who might benefit from a wellness screening
12. Describe patient characteristics for an individual at risk for infectious disease, including HIV, Hepatitis C, Group A Streptococcus, Influenza, and COVID-19

Faculty

Joshua Davis Kinsey, PharmD

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Elizabeth Skoy, PharmD

Disclosures:

Elizabeth Skoy has no relevant financial relationships with ineligible companies to disclose.

Brett Barker, PharmD

Disclosures:

Brett Barker reports that he is an employee of Nucara. All relevant financial relationships have been mitigated.

Anthony J. Bolus, PharmD, RPh

Disclosures:

Anthony J. Bolus has no relevant financial relationships with ineligible companies to disclose.

Julie Breuer

Disclosures:

Julie Breuer has no relevant financial relationships with ineligible companies to disclose.

Patrick Devereux, PharmD, RPh

Disclosures:

Patrick Devereux has no relevant financial relationships with ineligible companies to disclose.

Alex Evans, PharmD, MBA

Disclosures:

Alex Evans has no relevant financial relationships with ineligible companies to disclose.

Michele Fountain, PharmD

Disclosures:

Michele Fountain has no relevant financial relationships with ineligible companies to disclose.

John A. Galdo, PharmD, MBA, BCPS, BCGP

Disclosures:

John Galdo reports that he is CEO of Seguridad and his spouse works for Eli Lilly and was an employee of Prime Therapeutics. All relevant financial relationships have been mitigated.

David Hachey, PharmD, AAHIVP

Disclosures:

David Hachey has no relevant financial relationships with ineligible companies to disclose.

Monica Nikseresht

Disclosures:

Monica Nikseresht has no relevant financial relationships with ineligible companies to disclose.

Alexis Page, PharmD

Disclosures:

Alexis Page has no relevant financial relationships with ineligible companies to disclose.

Kathryn Schott, PhD

Disclosures:

Kathryn Schott has no relevant financial relationships with ineligible companies to disclose.

Beth Cady, PharmD

Disclosures:

Beth Cady has no relevant financial relationships with ineligible companies to disclose.

Course Details